Filing status
- Accounts due
- 30 April 2027
- Last accounts
- 31 July 2025
- Conf. stmt due
- 18 March 2027
- Last conf. stmt
- 4 March 2026
Complement Genomics Limited
- Incorporated
- 21 February 2000 (26 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Owned by
- Louise Claire AllcroftNeil Fraser Sullivan
- Accounts type
- Total exemption full
- Region
- North East
- Address
- The Durham Genome CentrePark House Station RoadLanchesterDurhamDH7 0EX
Charges
- Total
- 3
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 1
Officers 2 active
Officer details are public data from the Companies House register.
Sullivan, Neil Fraser, Dr
Secretary · Appointed 7 August 2014
Director · Appointed 4 March 2000
Also at Durham Genome Centre Ltd · more companies
English
Born February 1972 (54)
Officer history (5 former)
7 August 2014
Appointed Sullivan, Neil Fraser, Dr as Secretary
5 October 2009
2 November 2005
2 November 2005
2 November 2005
4 March 2000
4 March 2000
4 March 2000
4 March 2000
4 March 2000
21 February 2000
21 February 2000
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
Individual · Notified 25 May 2023
Owns 25–50% of shares
Holds 25–50% of voting rights
English
Born February 1972 (54)
Individual · Notified 6 April 2016
Owns 50–75% of shares
Holds 50–75% of voting rights
British
Born May 1959 (67)
Financials
Balance sheet as at 31 July 2025 · total exemption full accounts
- Net Assets
- £840,428
- Cash
- £58,727
- Employees
- 17
- Debt Ratio
- 22%
- Current Ratio
- 7.5x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fixed Assets | £391,740 | £460,915 | £465,672 | £439,145 | £456,278 | £372,288 | £306,434 |
| Current Assets | £684,448 | £715,378 | £1,397,675 | £1,982,012 | £1,187,364 | £858,664 | £624,341 |
| Debtors | £378,957 | £568,817 | £595,535 | £559,398 | £391,295 | £388,799 | |
| Cash | £58,727 | £119,844 | £588,720 | £1,138,106 | £401,257 | £265,316 | £73,440 |
| Creditors (< 1 year) | £90,949 | £145,306 | £144,793 | £450,794 | £290,208 | £197,558 | £202,594 |
| Creditors (> 1 year) | £50,307 | £8,446 | £45,806 | £110,545 | £212,452 | £221,403 | £95,520 |
| Net Current Assets | £593,499 | £570,072 | £1,252,882 | £1,531,218 | £897,156 | £661,106 | £421,747 |
| Net Assets | £840,428 | £1,022,541 | £1,588,636 | £1,781,024 | £1,140,982 | £811,991 | £632,661 |
| Shareholder Funds | £1,022,541 | £1,588,636 | £1,781,024 | £1,140,982 | £811,991 | £632,661 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 29 March 2026 | Confirmation statement with updates | 4 March 2026 | ||
| 17 March 2026 | Total exemption full accounts | 31 July 2025 | ||
| 22 April 2025 | Unaudited abridged accounts | 31 July 2024 | ||
| 6 March 2025 | Confirmation statement with updates | 4 March 2025 | ||
| 5 November 2024 | Statement of capital following an allotment of shares |
Some other companies at this address
Other companies in this industry
Middlesex
Manchester
Hartley Wintney
Pampisford
Cambridge
Chalgrove
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →